These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27625065)

  • 1. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
    Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
    BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 3. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I; Valasoulis G; Founta C; Kyrgiou M; Nasioutziki M; Daponte A; Koliopoulos G; Malamou-Mitsi V; Karakitsos P; Paraskevaidis E
    Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of p16
    Rezhake R; Wang Y; Chen F; Hu SY; Zhang X; Cao J; Qiao YL; Zhao FH; Arbyn M
    Cancer Cytopathol; 2021 Sep; 129(9):679-692. PubMed ID: 33826790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
    Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+.
    Stănculescu R; Brătilă E; Bauşic V; Vlădescu T
    Rom J Morphol Embryol; 2013; 54(4):1061-5. PubMed ID: 24399002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
    Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; De Marco L; Giorgi-Rossi P; Pontenani G; Rosso S; Sani C; Sintoni C; Segnan N; Zorzi M; Cuzick J; Rizzolo R; Ronco G;
    Lancet Oncol; 2008 Oct; 9(10):937-45. PubMed ID: 18783988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.
    Carozzi F; Cecchini S; Confortini M; Becattini V; Cariaggi MP; Pontenani G; Sani C; Ciatto S
    Cancer; 2006 Apr; 108(2):119-23. PubMed ID: 16411180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
    Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
    Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of p16(INK4a) expression in cervical intraepithelial neoplasia specimens, including women with HIV-1.
    Nicol AF; Golub JE; e Silva JR; Cunha CB; Amaro-Filho SM; Oliveira NS; Menezes W; Andrade CV; Russomano F; Tristão A; Grinsztejn B; Friedman RK; Oliveira MP; Pires A; Nuovo GJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):571-7. PubMed ID: 22850945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
    J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
    Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
    BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.